Inrose

Therapeutic Segment:
Anti-anemic

Generic Name:
Iron Sucrose

Description:
INROSE injection is a brown, sterile,solution aqueous,
complex of polynuclear Iron (III)-hydroxide in sucrose for
intravenous use.

Indication:

  • Where there is a clinical need to deliver iron rapidly to iron stores.
  • Patients who can not tolerate oral iron therapy or who are non-compliant.
  • In active inflammatory bowel disease where oral iron preparations are ineffective.
  • Non-dialysis dependent-chronic kidney diseases (NDD-CKD) patients receiving an Erythropoietin.
  • Non-dialysis dependent-chronic kidney diseases (NDD-CKD) patients not receiving an Erythropoietin.Hemodialysis dependent-chronic kidney disease (HDD-CKD) patients receiving an Erythropoietin.
  • Peritoneal dialysis dependent-chronic kidney disease (HDD-CKD) patients receiving an Erythropoietin.

Formulation:

  • Injection

Strength:

  • 100mg/2ml

Pack Size:

  • 5’s
Inrose-packshot